fda bpc 157 compounding category 2 list Peptide Update: Removals Explained Updated 2026 FDA Category 2

Updated 2026 FDA Category 2 peptide list As the science and regulations continue to develop, it's important to work with providers who stay informed and prioritize safe, medically guided protocols. At FDA Panel to Review 7 Peptides in July (2026) Category 1 vs. Category 2. The FDA's peptide update, explained. Category 2 peptides are on the FDA's difficult to compound list, which effectively blocks licensed pharmacies from producing them. Category 1 means Industry Update: Interim 503A and 503B Bulks Lists New Revisions The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step

SKU: 85237390647 · From lagence-mr.com